Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women

Chinese Journal of Cancer

Volumn 30, Issue 5, 2011, Pages 344-350

  Hasimu, Ayshamgul ^a   Ge, Lin ^b   Li, Qiao Zhi ^a   Zhang, Rui Ping ^a   Guo, Xia ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Wujiaqu Hospital   (China)

Author keywords

Cervical squamous cell carcinoma; HPV16; Toll like receptors; Uighur women

Indexed keywords

TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER TISSUE; CHINA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; UPREGULATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 79958163694     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10456     Document Type: Article

References (24)

1. Guzalnur, Peng ZL, Guo Y. Different expression of HPV and its subtype in cervical cancer tissue between Sichuan Han and Xinjiang Uighur women [J]. Chin J Microbiol Immunol, 2004,24 (5):406. [in Chinese]
2. Lalai S, Peng YH, Zhou K, et al. The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang [J]. J Xinjiang Med Univ, 2006,29(7):569-571. [in Chinese]
3. Maclag PC, Schlcht NF, Souza PS, et al. Major histocompatibility complex and human papillomavirus infection in Brazilian women [J]. Cancer Epidemiol Biomakers Prev, 2000,9(11):1183-1191.
4. Akira S, Hemmi H. Recognition of pathogen-associated molecular patens by TLR family [J]. Immunol Lett, 2003,85(2): 85-95.
5. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitates evasion of immune surveillance [J]. Cancer Res, 2005,65(12):5009-5014.
6. Wang H, Rayburn E, Zhang R. Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics [J]. Curr Pharm Des, 2005,11(22):2889-2907.
7. Chen R, Alvero AB, Silasi DA, et al. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway [J]. Am J Reprod Immunol, 2007,57(2):93-107.
8. Li H, Han Y, Guo Q, et al. Cancer-expanded myeloid-derived suppressor cells induce energy of NK cells through membrane-bound TGF-beta1 [J]. J Immunol, 2009,182(1):240-249.
9. Lalai S, Amy E, Aili M, et al. Detection of human papilloma virus DNA in cervical squamous cell carcinoma in Xinjiang Uighur women [J]. Chin J Obstet Gynecol, 1997,32(7):405-408. [in Chinese]
10. Gokdeniz R, Ozen S, Mizrak B, et al. GnRH agonist decreases endothelial nitric oxide synthase (eNOS) expression in leiomyoma [J]. Int J Gynaecol Obstet, 2000,70 (3):347-352.
11. Lee JW, Choi JJ, Seo ES, et al. Increased toll-like receptor 9 expression in cervical neoplasia [J]. Mol Carcinogen, 2007,46 (11):941-947.
12. Thompson JM, Iwasaki A. Toll-like receptors regulation of viral infection and disease [J]. Adv Drug Deliv Rev, 2008,60 (7): 786-794.
13. Yang R, Murillo FM, Cui H, et al. Papilloma virus HPV1-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and TH1 immune responses via MyD88 [J]. Virol, 2004,78(20):11152-11160.
14. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer [J]. Nat Rev Cancer, 2009,9(1):57-63.
15. Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors [J]. Gastroenterology, 2007,133(6):1869-1881.
16. Zhou M, McFarland-Mancini MM, Funk HM, et al. Toll-like receptor expression in normal ovary and ovarian tumors [J]. Cancer Immunol Immunother, 2009,58(9):1375-1385.
17. Kundu SD, Lee C, Billips BK, et al. The toll-like receptor pathway: an ovel mechanism of infection-induced carcinogenesis of prostate epithelial cells [J]. Prostate, 2008,68 (2):223-229.
18. Li H, Han Y, Guo Q, et al. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta1 [J]. J Immunol, 2009,182(1):240-249.
19. Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway where as its lipopolysaccharide attenuates antitumor activities of human mononuclear cells [J]. Clin Cancer Res, 2008,14(10):2909-2917.
20. He W, Liu Q, Wang L, et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance [J]. Mol Immunol, 2007,44(11):2850-2859.
21. Hasan UA, Bates E, Takeshita F, et al. TLR9 expression and function is abolished by the cervical cancer-as sociated human papillomavirus type 16 [J]. J Immunol, 2007,178 (5):3186-3197
22. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance [J]. Cancer Res, 2005,65(12):5009-5014.
23. Fahey L, Raff A, Da Silva, et al. Reversal of human papillomavirus-specific T cell immune suppression through TLR7 agonist treatment of Langerhans cells exposed to human papillomavirus type 16 [J]. Immunol, 2009,182(5):2919-2928.
24. Yu L, Wang L, Li M, et al. Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia [J]. Cancer Immunol Immunother, 2010,59(7):1021-1028.